N/A
Completed N=982
ARgentinean Risk Assessment Registry in ACS; the ARRA-RACS Study
Source: ClinicalTrials.gov NCT01377402 ↗Enrolled (actual)
982
Serious AEs
0.0%
Results posted
Dec 2015
Primary outcomePrimary: Total Mortality. — 173 participants
Summary
The first aim of this trial is to assess the long-term prognostic value of Omega-3 index, which is a measure of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) relative to other fatty acids in the erythrocyte membrane, in an unselected, regional multicenter observational study of 982 chest pain patients admitted to the emergency unit, employing blood samples collected at admission.
The second purpose of this study is to evaluate the prognostic utility of vitamin D in the same population.
The third purpose of this study is to assess the incremental prognostic value of B-type natriuretic peptide (BNP) and high-sensitive C-reactive protein (hsCRP).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Total Mortality. |
173 | — |
| SECONDARY Participants With Cardiac Events During Follow-up. |
92; 51 | — |
Eligibility Criteria
Inclusion Criteria
- adults > 18 years able to give informed consent
- a history of chest pain or other symptoms suggestive of an ACS leading to admission at the emergency unit
Exclusion Criteria
- < 18 years of age
- Unwillingness or incapacity to provide informed consent
- Prior admission resulting in inclusion in the present study
Data sourced from ClinicalTrials.gov (NCT01377402). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.